Alessandra Narcisi

13PUBLICATIONS
103CO-AUTHORS
Epidemiological methodsMolecular targetsAllergyCancer therapy (excl. chemotherapy and radiation therapy)Pain
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 05, 2026
Treat-to-Target in Atopic Dermatitis: An Italian Survey and Expert Opinion on Clinical Practice and Unmet Needs.

|Oct 01, 2026
Long-Term Disease Control During Continuous Treatment with Upadacitinib and Baricitinib for Moderate-to-Severe Atopic Dermatitis: a Real-World Monocentric Retrospective Study.

|Jul 25, 2026
JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study.

|Jul 03, 2026
Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

Pageof 3

Frequent Collaborators

10 joint publications

Antonio Costanzo

9 joint publications

Luigi Gargiulo

6 joint publications

Silvia Mariel Ferrucci

6 joint publications

Mario Valenti